Search This Blog

Thursday, July 23, 2020

Exact Sciences may gain from Humana at-home screening kit initiative – Evercore

According to Evercore ISI, Exact Sciences (EXAS +3.3%) may get a boost from Humana’s initiative to send ~1M at-home preventative care screening kits to its members to identify early complications associated with diabetes and colon cancer.
Exact’s top revenue producer is its Cologuard screening test for colon cancer.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)